A Phase I/Ib Open-Label, First-In-Human, Single Agent, Dose Escalation And Expansion Study Of A Her2-Targeted T Cell Engager (Sar443216) In Patients With Relapsed/Refractory Her2-Expressing Solid Tumors
SAR443216
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Phase I/Ib Open-Label, First-In-Human, Single Agent, Dose Escalation And Expansion Study Of A Her2-Targeted T Cell Engager (Sar443216) In Patients With Relapsed/Refractory Her2-Expressing Solid Tumors ### Output: SAR443216